Since the first use of CRISPR-based gene editing, the field has evolved at an exceptional pace exhibting an average growth in publications of 54% in the last decade (2014-2023). This sustained and extensive interest has resulted in a plethora of publications exploring the use of CRISPR in treating hard to treat/cure diseases, disease diagnostics as well as identification of genes underlying various disorders.